Fanny Cavalie's most recent trade in Foghorn Therapeutics Inc was a trade of 11,000 Common Stock done at an average price of $6.6 . Disclosure was reported to the exchange on March 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Foghorn Therapeutics Inc | Fanny Cavalie | Chief Strategy/Bus Ops Officer | Sale of securities on an exchange or to another person at price $ 6.56 per share. | 11 Mar 2024 | 11,000 | 75,992 | - | 6.6 | 72,134 | Common Stock |
Foghorn Therapeutics Inc | Fanny Cavalie | Chief Strategy/Bus Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
Foghorn Therapeutics Inc | Fanny Cavalie | Chief Strategy/Bus Ops Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 65,000 | 65,000 | - | - | Stock Option (right to buy) |